Los Angeles, CA 9/14/18—Strategic Directions International (SDi), part of Science and Medicine Group, announced the release of their 2018 Bioprocessing Market Analysis and Perspectives report. The report details market data and commentary for five key bioprocessing technologies with segmentation and growth by product type, region, and end market; vendor share data and commentary are also provided. In addition, a survey of 212 bioprocessing professionals from North America, Europe, and Asia explores in detail their technology usage, vendor usage, vendor satisfaction, and budget expectations.

“The total market for bioprocessing instruments and equipment, including the sum of initial systems, aftermarket, and instrument servicing, and is expected to approach $12.4 billion by 2022,” said Mike Tice, Senior Vice President, Business Intelligence at SDi. “Given the importance of bioprocessing technologies and their continued growth and ramifications into many different areas of the modern global economy, the total market needs to be segmented in various ways to make more sense of the total industry.”

The goal of this report is to provide a detailed overview of the current market situation and projected potential for key bioprocessing technologies. This report identifies, in both quantitative and qualitative terms, the structure and composition of the worldwide bioprocessing market. Technical, business, and economic trends are assessed with emphasis on the impact these forces have on technology demand. The market information in this report, with the exception of the end-user survey, represents estimates of the market and provides perspectives and the relative significance of specific trends within this market.

The 2018 Bioprocessing Market Analysis and Perspectives is the most accurate, detailed and concise market research document on the bioprocessing market available anywhere. Additionally, users will receive the report in a PDF as well as an editable PowerPoint format.

A complimentary Executive Summary can be downloaded here: strategic-directions.com/product/2018-bioprocessing-marke…

Bioprocessing instruments and techniques have become influential in everything from generating high yield pharmaceutical precursors, to biofuel conversion from biomass. This report delves into market size and growth data for bioreactors, cell culture and media, supplements, filtration, and process chromatography, covering both upstream and downstream processes. It can serve as a valuable reference for corporate planning, strategic marketing, business valuation, acquisition due diligence, and other business activities.

Strategic Directions International (SDi), a leading international management-consulting firm in the highly specialized field of analytical instruments, was acquired by BioInformatics Inc in 2014. The two firms combined to form the premier research and advisory firm serving the life science and analytical instrument industry. By leveraging our verified online professional network of tens of thousands of scientists in The Science Advisory Board®, we have supported more than 500 companies and provided insights that lead to better business decisions. Our expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customers’ brand loyalty, and evaluating brand strength and positioning, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning. SDi and BioInformatics Inc are members of Science and Medicine Group, supporting life science, radiology, dentistry, analytical instrument, and clinical diagnostic companies.

Mike Tice
Senior Vice President of Business Intelligence
Strategic Directions International
A division of BioInformatics Inc.
6242 Westchester Parkway, Suite 100
Los Angeles, CA 90045-4820
United States
Phone: 310.641.4982
mtice@strategic-directions.com

 

This release was published on openPR.